Predictive Value of Cardiovascular Risk Factors for Risk Assessment in Cohort of Shiraz Heart Study

Authors

M Fathzadeh1,*, Mohammad Javad Zibaeenezhad2, MA Babaee Bigi1, Shahdad Khosropanah1, Mahmood Zamirian3, Kamran Aghasadeghi1, Alireza Moaref1, Firoozeh Abtahi4, Seyed Taghi Heydari1, Mohammad Hassan Eftekhari1
2Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran, Shiraz, Iran
3Department of Cardiology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
4cardiology, cardiovascular research center, shiraz university of medical sciences, shiraz, Iran
*Corresponding Author: Corresponding author: M Fathzadeh, E-mail: Email: [email protected]

International Cardiovascular Research Journal:Vol. 4, issue 1; e67646
Published online:Mar 30, 2010
Article type:Research Article
Received:Feb 19, 2010
Accepted:Mar 31, 2010
How to Cite:Fathzadeh M, Zibaeenezhad MJ, Babaee Bigi M, Khosropanah S, Zamirian M, et al. Predictive Value of Cardiovascular Risk Factors for Risk Assessment in Cohort of Shiraz Heart Study. Int Cardiovasc Res J. 2010;4(1):e67646. doi:

Abstract

Background: Risk assessment for fast growing burden of cardiovascular diseases is very important and difficult.
As a response to this challenge, in particular, genetic risk factors which potentially modify risk, we conducted
a survey of primary data registry of Shiraz Heart Study on integration and application of family history
data in prevention of cardiovascular disorders.
Method: This study is a longitudinal cohort project to be extended from subpopulations of different job groups
to the community.
Results: Parental family history of MI, diabetes mellitus (DM), hyperlipidemia (HPL), hypertension (HTN) was
reported more frequently among females than males. Histories of MI, DM, HPL, and HTN in both parents were
respectively positive in 2.6%, 2%, 4.6%, and 7.9 % of the participants. Odd ratios (OR) for risk of MI from family
history of MI were 2.7; risk of DM from family history of DM 4.5; risk of HPL from family history of HPL
2.04; and risk of HTN from family history HTN 4.7. Also, family history of MI modifies risk of HPL (OR=1.7,
P<0.0001); and family history of DM modifies risk of HPL (OR=2.04, P<0.0001).
Conclusion: Our primary result shows potent application of family history data in risk assessment of cardiovascular
outcome. In particular, HTN appears as a silent and leading risk modifier. In regard to the course of
continuing Shiraz Heart Study integration of family history of risk factors crucial in public health we suggest to
adopt a network of electronic health records from the “Health House” to the “Heart House”.

Fulltext

The full text is available in PDF.

References

  • 1.
    The references are available in PDF.

Copyright

© 2010, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

2
Aug
2016

The role of the history of coronary heart disease among second degree relatives for predicting coronary artery disease

Saeed Alipour Parsa,
Farzam Saemifar,
Isa Khaheshi,
Mohammadreza Naderian

Alipour Parsa S, Saemifar F, Khaheshi I, Naderian M. The role of the history of coronary heart disease among second degree relatives for predicting coronary artery disease. Int J Cardiovasc Pract. 2016;1(2):e130037. doi: https://doi.org/10.20286/ijcp-010202

24
Apr
2017

Risk of Coronary Heart Events Based on Rose Angina Questionnaire and ECG Besides Diabetes and Other Metabolic Risk Factors: Results of a 10-Year Follow-up in Tehran Lipid and Glucose Study

Mohammad Ali Mansournia,
Kourosh Holakouie-Naieni,
Noushin Fahimfar,
Amir Almasi-Hashiani,
Zahra Cheraghi,
Erfan Ayubi
,et al.

Mansournia MA, Holakouie-Naieni K, Fahimfar N, Almasi-Hashiani A, Cheraghi Z, et al. Risk of Coronary Heart Events Based on Rose Angina Questionnaire and ECG Besides Diabetes and Other Metabolic Risk Factors: Results of a 10-Year Follow-up in Tehran Lipid and Glucose Study. Int J Endocrinol Metab. 2017;15(2):e42713. doi: https://doi.org/10.5812/ijem.42713

4
Dec
2021
Evaluation of Cardiovascular Diseases Risk in the Iranian Population

Evaluation of Cardiovascular Diseases Risk in the Iranian Population

Meisam Akhlaghdoust,
Davoud Pirani,
Mohamad Nasiri,
Sahar Lashkari Ahangarani,
Nazgol Haghsetan,
Mohsen Karbalaiea
,et al.

Akhlaghdoust M, Pirani D, Nasiri M, Lashkari Ahangarani S, Haghsetan N, et al. Evaluation of Cardiovascular Diseases Risk in the Iranian Population. Artif Intell Precis Med. 2021;1(1):e121308. doi: https://doi.org/10.5812/pmco.121308

30
Sep
2005

The relationship between ischemic heart disease and coronary risk factors in population aged over 25 in Qazvin: A population-based study

H Fakhrzadeh,
B Larijani,
F Bandarian,
H Adibi,
T Samavat,
H Malekafzal
,et al.

Fakhrzadeh H, Larijani B, Bandarian F, Adibi H, Samavat T, et al. The relationship between ischemic heart disease and coronary risk factors in population aged over 25 in Qazvin: A population-based study. J Inflamm Dis. 2024;9(2):e155123. doi:

10
Mar
2018
The Trend of Changes in the Risk Factors of Coronory Heart Disease from 1980 to 2010 in Iran

The Trend of Changes in the Risk Factors of Coronory Heart Disease from 1980 to 2010 in Iran

Manijeh Alimohammadi,
Yousef Alimohamadi,
Malihe Khoramdad,
Mohammad Shahbaz,
Amir Abbas Shokraeian,
Firooz Esmaeilzadeh

Alimohammadi M, Alimohamadi Y, Khoramdad M, Shahbaz M, Shokraeian AA, et al. The Trend of Changes in the Risk Factors of Coronory Heart Disease from 1980 to 2010 in Iran. Shiraz E-Med J. 2018;19(4):e59823. doi: https://doi.org/10.5812/semj.59823

More by these authors

M FathzadehPubMedScholar
Mohammad Javad ZibaeenezhadPubMedScholar
MA Babaee BigiPubMedScholar
Shahdad KhosropanahPubMedScholar
Mahmood ZamirianPubMedScholar
Kamran AghasadeghiPubMedScholar
Alireza MoarefPubMedScholar
Firoozeh AbtahiPubMedScholar
Seyed Taghi HeydariPubMedScholar
Mohammad Hassan EftekhariPubMedScholar
Share
Cited by
Metrics